Patents by Inventor Alessandro MARESTA

Alessandro MARESTA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12485119
    Abstract: The disclosure relates to methods of reducing the risk of disease progression in a patient with pulmonary arterial hypertension (PAH), comprising administering to a patient in need thereof, an initial triple combination therapy of an endothelin receptor antagonist (ERA), a phosphodiesterase type 5 (PDE-5) inhibitor, and a prostacyclin receptor agonist (IP receptor agonist).
    Type: Grant
    Filed: November 27, 2020
    Date of Patent: December 2, 2025
    Assignee: Actelion Pharmaceuticals Ltd
    Inventors: Alessandro Maresta, Loïc Perchenet
  • Publication number: 20230032813
    Abstract: The disclosure relates to methods of reducing the risk of disease progression in a patient with pulmonary arterial hypertension (PAH), comprising administering to a patient in need thereof, an initial triple combination therapy of an endothelin receptor antagonist (ERA), a phosphodiesterase type 5 (PDE-5) inhibitor, and a prostacyclin receptor agonist (IP receptor agonist).
    Type: Application
    Filed: November 27, 2020
    Publication date: February 2, 2023
    Inventors: Alessandro MARESTA, Loïc PERCHENET